Folgen
Ute I. Schwarz
Ute I. Schwarz
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei lhsc.on.ca
Titel
Zitiert von
Zitiert von
Jahr
Identification of functionally variant MDR1 alleles among European Americans and African Americans
RB Kim, BF Leake, EF Choo, GK Dresser, SV Kubba, UI Schwarz, ...
Clinical Pharmacology & Therapeutics 70 (2), 189-199, 2001
13002001
Genetic determinants of response to warfarin during initial anticoagulation
UI Schwarz, MD Ritchie, Y Bradford, C Li, SM Dudek, A Frye-Anderson, ...
New England Journal of Medicine 358 (10), 999-1008, 2008
7632008
Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine
GK Dresser, DG Bailey, BF Leake, UI Schwarz, PA Dawson, DJ Freeman, ...
Clinical pharmacology & therapeutics 71 (1), 11-20, 2002
7422002
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
GM Cooper, JA Johnson, TY Langaee, H Feng, IB Stanaway, UI Schwarz, ...
Blood, The Journal of the American Society of Hematology 112 (4), 1022-1027, 2008
5332008
Intestinal drug transporter expression and the impact of grapefruit juice in humans
H Glaeser, DG Bailey, GK Dresser, JC Gregor, UI Schwarz, JS McGrath, ...
Clinical Pharmacology & Therapeutics 81 (3), 362-370, 2007
4842007
Identification and functional characterization of a new CYP2C9 variant (CYP2C9* 5) expressed among African Americans
LJ Dickmann, AE Rettie, MB Kneller, RB Kim, AJJ Wood, CM Stein, ...
Molecular pharmacology 60 (2), 382-387, 2001
3642001
MDR1 Gene Polymorphisms Affect Therapy Outcome in Acute Myeloid Leukemia Patients
T Illmer, US Schuler, C Thiede, UI Schwarz, RB Kim, S Gotthard, D Freund, ...
Cancer research 62 (17), 4955-4962, 2002
3472002
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects
GK Dresser, UI Schwarz, GR Wilkinson, RB Kim
Clinical Pharmacology & Therapeutics 73 (1), 41-50, 2003
3332003
Human skeletal muscle drug transporters determine local exposure and toxicity of statins
MJ Knauer, BL Urquhart, HE Meyer zu Schwabedissen, UI Schwarz, ...
Circulation research 106 (2), 297-306, 2010
2472010
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
UI Schwarz
European journal of clinical investigation 33, 23-30, 2003
2402003
Effect of drug transporter genotypes on pravastatin disposition in European-and African-American participants
RH Ho, L Choi, W Lee, G Mayo, UI Schwarz, RG Tirona, DG Bailey, ...
Pharmacogenetics and genomics 17 (8), 647-656, 2007
2182007
Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care
MK DeGorter, RG Tirona, UI Schwarz, YH Choi, GK Dresser, N Suskin, ...
Circulation: Cardiovascular Genetics 6 (4), 400-408, 2013
2122013
P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans.
UI Schwarz, T Gramatté, J Krappweis, R Oertel, W Kirch
International journal of clinical pharmacology and therapeutics 38 (4), 161-167, 2000
1982000
Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception
UI Schwarz, B Büschel, W Kirch
British journal of clinical pharmacology 55 (1), 112, 2003
1812003
Grapefruit juice ingestion significantly reduces talinolol bioavailability
UI Schwarz, D Seemann, R Oertel, S Miehlke, E Kuhlisch, MF Fromm, ...
Clinical Pharmacology & Therapeutics 77 (4), 291-301, 2005
1722005
Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters
MG Mooij, UI Schwarz, BAE De Koning, JS Leeder, R Gaedigk, ...
Drug Metabolism and Disposition 42 (8), 1268-1274, 2014
1592014
Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
BL Urquhart, JA Ware, RG Tirona, RH Ho, BF Leake, UI Schwarz, H Zaher, ...
Pharmacogenetics and genomics 18 (5), 439-448, 2008
1572008
Induction of intestinal P‐glycoprotein by St John's wort reduces the oral bioavailability of talinolol
UI Schwarz, H Hanso, R Oertel, S Miehlke, E Kuhlisch, H Glaeser, M Hitzl, ...
Clinical Pharmacology & Therapeutics 81 (5), 669-678, 2007
1552007
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy
IY Gong, RG Tirona, UI Schwarz, N Crown, GK Dresser, S LaRue, ...
Blood, The Journal of the American Society of Hematology 118 (11), 3163-3171, 2011
1112011
Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions
P Madadi, D Hildebrandt, IY Gong, UI Schwarz, C Ciszkowski, CJD Ross, ...
Pediatrics 126 (4), e986-e989, 2010
1042010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20